Kala Pharmaceuticals, Inc. (0JQ2.L)
USD 6.03
(-3.51%)
USD 6.03
(-3.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -27.92 Million | -78.9 Million | -108.23 Million | -90.69 Million | -92.72 Million | -54.12 Million |
| Net Income | -42.19 Million | -44.82 Million | -142.6 Million | -104.32 Million | -94.34 Million | -66.73 Million |
| Depreciation & Amortization | 303 Thousand | 537 Thousand | 975 Thousand | 912 Thousand | 843 Thousand | 955 Thousand |
| Deferred income taxes | 1.82 Million | - | 5.41 Million | -5000.00 | - | 390 Thousand |
| Stock-based compensation | 7.46 Million | 7 Million | 16.08 Million | 13.31 Million | 9.99 Million | 8.61 Million |
| Change in working capital | 8.89 Million | 491 Thousand | -10.61 Million | -3.57 Million | -11.93 Million | 2.38 Million |
| Other non-cash items | -4.21 Million | -42.12 Million | 22.5 Million | 2.98 Million | 2.73 Million | 274 Thousand |
| Investing Cash Flow | -429 Thousand | 62.71 Million | 70.8 Million | -78.2 Million | -1.33 Million | -1.57 Million |
| Investments in PPE | -610 Thousand | -313 Thousand | -886 Thousand | -1.94 Million | -1.33 Million | -1.57 Million |
| Acquisitions | 47 Thousand | 62.9 Million | -4.65 Million | 2.07 Million | - | - |
| Investment purchases | -9.86 Million | -4.99 Million | - | -113.59 Million | - | - |
| Sales/Maturities of investments | 10 Million | 5 Million | 76.25 Million | 37.32 Million | - | - |
| Other Investing Activities | -563 Thousand | 114 Thousand | 92 Thousand | -2.07 Million | - | - |
| Financing Cash Flow | 8.5 Million | -7.94 Million | 42.55 Million | 160.62 Million | 8.98 Million | 124.1 Million |
| Debt repayment | -10 Million | -40.03 Million | -263 Thousand | -32 Thousand | -30 Thousand | -21.84 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 365 Thousand | - | - | - | - | - |
| Common Stock Issuance | 20.54 Million | 31.79 Million | 42.81 Million | 158.55 Million | 8.42 Million | 70.76 Million |
| Other Financing Activities | -2.04 Million | 301 Thousand | 79.36 Million | 2.1 Million | 587 Thousand | 75.18 Million |
| Accounts receivables | 78 Thousand | 15.13 Million | -5.75 Million | 1.95 Million | -11.56 Million | -157.85 Million |
| Accounts payables | -1.9 Million | -2.07 Million | 3.23 Million | -924 Thousand | -2.77 Million | 4.08 Million |
| Inventory | 7.54 Million | 1.7 Million | -6.25 Million | -2.36 Million | -4.27 Million | -3.86 Million |
| Other working capital | 3.17 Million | -14.27 Million | -1.83 Million | -2.24 Million | 6.66 Million | 160.01 Million |
| Cash at beginning of period | 70.49 Million | 94.87 Million | 89.75 Million | 98.03 Million | 183.1 Million | 114.69 Million |
| Cash at end of period | 50.89 Million | 70.74 Million | 94.87 Million | 89.75 Million | 98.03 Million | 183.1 Million |
| Capital Expenditure | -610 Thousand | -313 Thousand | -886 Thousand | -1.94 Million | -1.33 Million | -1.57 Million |
| Effect of forex changes on cash | 250 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -19.6 Million | -24.13 Million | 5.12 Million | -8.27 Million | -85.07 Million | 68.4 Million |
| Free Cash Flow | -28.53 Million | -79.22 Million | -109.12 Million | -92.63 Million | -94.05 Million | -55.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.57 Million | -11.8 Million | -8.62 Million | -42.19 Million | -8.7 Million | -10.41 Million |
| Depreciation & Amortization | 61 Thousand | 66 Thousand | 70 Thousand | 303 Thousand | 79 Thousand | 77 Thousand |
| Deferred income taxes | - | - | -2.38 Million | 1.82 Million | - | - |
| Stock-based compensation | 1.88 Million | 2.37 Million | 2.37 Million | 7.46 Million | 2.4 Million | 1.36 Million |
| Change in working capital | -2.04 Million | -2.04 Million | -2.17 Million | 8.89 Million | 8.9 Million | 758 Thousand |
| Other non-cash items | 2.54 Million | 3.26 Million | 3.04 Million | -4.21 Million | -5.63 Million | 621 Thousand |
| Investing Cash Flow | -36 Thousand | -13 Thousand | -7000.00 | -429 Thousand | 9.71 Million | -10.03 Million |
| Investments in PPE | -36 Thousand | -13 Thousand | -7000.00 | -610 Thousand | -281 Thousand | -214 Thousand |
| Acquisitions | - | - | -47 Thousand | 47 Thousand | - | 47 Thousand |
| Investment purchases | - | - | - | -9.86 Million | - | -9.86 Million |
| Sales/Maturities of investments | - | - | 47 Thousand | 10 Million | 10 Million | -47 Thousand |
| Other Investing Activities | - | -13 Thousand | -610 Thousand | -563 Thousand | - | 47 Thousand |
| Financing Cash Flow | 14.97 Million | 8.44 Million | 2.53 Million | 8.5 Million | 40 Thousand | 3.07 Million |
| Debt repayment | - | - | - | -10 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -40 Thousand | 365 Thousand | 40 Thousand | - |
| Common Stock Issuance | 14.97 Million | 8.55 Million | 2.53 Million | 20.54 Million | 40 Thousand | 3.07 Million |
| Other Financing Activities | - | -119 Thousand | 18.61 Million | -2.04 Million | - | - |
| Accounts receivables | - | - | - | 78 Thousand | - | -2000.00 |
| Accounts payables | -67 Thousand | -187 Thousand | 132 Thousand | -1.9 Million | 27 Thousand | -237 Thousand |
| Inventory | - | - | -7.54 Million | 7.54 Million | 5.24 Million | 111 Thousand |
| Other working capital | -1.98 Million | -1.85 Million | -2.31 Million | 3.17 Million | 3.63 Million | 886 Thousand |
| Cash at beginning of period | 48.47 Million | 50.89 Million | 56.06 Million | 70.49 Million | 49.25 Million | 63.81 Million |
| Cash at end of period | 54.19 Million | 48.47 Million | 50.89 Million | 50.89 Million | 56.06 Million | 49.25 Million |
| Capital Expenditure | -36 Thousand | -13 Thousand | -7000.00 | -610 Thousand | -281 Thousand | -214 Thousand |
| Effect of forex changes on cash | - | - | 13.06 Million | 250 Thousand | -13.06 Million | - |
| Net cash flow / Change in cash | 5.71 Million | -2.41 Million | -5.16 Million | -19.6 Million | 6.8 Million | -14.55 Million |
| Free Cash Flow | -9.25 Million | -10.85 Million | -7.7 Million | -28.53 Million | -3.23 Million | -7.8 Million |
JYD
DAC
603177
688800
CMCAU
ATHARVENT